Search
forResearch 10 of 1000+
- UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy
- Abstract 5357: Targeting mTORC1 suppresses proliferation of keratinocyte stem cells and inhibits skin tumor promotion in mice
- Abstract 2559: Targeting mTORC1 may provide selectivity for inhibiting proliferation of hair follicle stem/progenitor cells during tumor promotion
- Microneedle-Enabled Exosome Therapy: From Tumor Targeting to Precision Treatment of Complex Diseases
- Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Targeting Pharmacological and Nanotechnology Based Therapeutics for Management of Hirsutism: A Comprehensive State-of-the-Art
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →